Rafael Jose
Ruiz Salmeron
Consultor Médico
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (9)
2022
-
Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry
Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487
-
Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure
Heart (British Cardiac Society), Vol. 108, Núm. 14, pp. 1098-1106
2020
-
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)
Frontiers in Immunology
-
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience
Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002
-
Major bleeding predictors in patients with left atrial appendage closure: The iberian registry ii
Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-11
2019
-
Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus
Frontiers in Immunology, Vol. 10, Núm. JUN
-
Left atrial appendage occlusion as adjunctive therapy to anticoagulation for stroke recurrence
Journal of Invasive Cardiology, Vol. 31, Núm. 8, pp. 212-216
-
Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II
Revista Espanola de Cardiologia, Vol. 72, Núm. 6, pp. 449-455
2013
-
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011
Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958